Formulation of water-soluble Buddleja globosa Hope extracts and characterization of their antimicrobial properties against Pseudomonas aeruginosa

被引:2
作者
Araya, Nicolas [1 ]
Leiva-Soto, Martin A. [1 ]
Bruna, Maria V. V. [1 ]
Castro-Munoz, Almendra [1 ]
Behrend-Keim, Beatriz [1 ]
Moraga-Espinoza, Daniel [1 ,2 ]
Bahamondez-Canas, Tania F. F. [1 ,2 ]
机构
[1] Univ Valparaiso, Escuela Quim & Farm, Fac Farm, Valparaiso, Chile
[2] Univ Valparaiso, Ctr Invest Farmacopea Chilena, Valparaiso, Chile
关键词
Buddleja globosa; natural extracts; phytopharmaceuticals; antimicrobials; Pseudomonas aeruginosa; ANTIBACTERIAL PROPERTIES; ANTIOXIDANT PROPERTIES; BIOFILM FORMATION; CATECHIN; ETHANOL; INFECTION; STIMULATE;
D O I
10.3389/fphar.2022.921511
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Buddleja globosa Hope (BG) extracts are traditionally used to treat skin and gastric ulcers due to their healing properties. Non-aqueous solvents such as ethanol and DMSO are usually used to extract naturally occurring compounds. However, the cytotoxicity of these solvents and the low water solubility of the extracted compounds can hinder their biomedical applications. To overcome the limited solubility of the BG extracts, we aimed to enhance the solubility by processing a standardized hydroalcoholic extract (BG-126) through spray drying (SD), with and without two solubility enhancers. Spray-dried BG (BG-SD) extracts and spray-dried BG extracts plus polyvinylpyrrolidone (BG-SD PVP) and Soluplus (R) (BG-SD SP) were developed starting from BG-126 (containing 53% ethanol). These four formulations were characterized by total phenolic content, water solubility at 25 degrees C and 37 degrees C, and antimicrobial properties against Pseudomonas aeruginosa. All the SD formulations presented a solubility that allowed them to reach maximum concentrations of 1,024 mu g/ml catechin for BG-SD and 2,048 mu g/ml catechin for BG-SD PVP and BG-SD SP for antimicrobial testing. BG-SD showed the highest antimicrobial potency with a minimum inhibitory concentration (MIC) of 512 mu g/ml catechin, followed by BG-126 with a MIC of 1,024 mu g/ml catechin and SP. BG-126 was also shown to inhibit biofilm formation, as well as the excipients PVP and SP. The spray-dried BG (BG-SD) extract represents a promising natural active component with enhanced antimicrobial properties against P. aeruginosa for further research and the development of novel phytopharmaceuticals.
引用
收藏
页数:11
相关论文
共 74 条
  • [1] Enzyme responsive copolymer micelles enhance the anti-biofilm efficacy of the antiseptic chlorhexidine
    Albayaty, Yassamin N.
    Thomas, Nicky
    Jambhrunkar, Manasi
    Al-Hawwas, Mohammed
    Kral, Anita
    Thorn, Chelsea R.
    Prestidge, Clive A.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 566 : 329 - 341
  • [2] Metabolite-enabled eradication of bacterial persisters by aminoglycosides
    Allison, Kyle R.
    Brynildsen, Mark P.
    Collins, James J.
    [J]. NATURE, 2011, 473 (7346) : 216 - +
  • [3] Anti-biofilm efficacy of a lactoferrin/xylitol wound hydrogel used in combination with silver wound dressings
    Ammons, Mary Cloud B.
    Ward, Loren S.
    James, Garth A.
    [J]. INTERNATIONAL WOUND JOURNAL, 2011, 8 (03) : 268 - 273
  • [4] Biofilm Formation on Silicone Tympanostomy Tubes With Polyvinylpyrrolidone Coating
    Antonelli, Patrick J.
    Sampson, Edith M.
    Ojano-Dirain, Carolyn
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2011, 137 (01) : 19 - 23
  • [5] Bactericidal activity of phosphoric acid, citric acid, and EDTA solutions against Enterococcus faecalis
    Arias-Moliz, Maria Teresa
    Ferrer-Luque, Carmen Maria
    Espigares-Rodriguez, Elena
    Liebana-Urena, Jose
    Espigares-Garcia, Miguel
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2008, 106 (02): : E84 - E89
  • [6] Avila JG, 1999, J ETHNOPHARMACOL, V66, P75, DOI 10.1016/S0378-8741(98)00203-7
  • [7] Analgesic, anti-inflammatory and antioxidant properties of Buddleja globosa, Buddlejaceae
    Backhouse, N.
    Rosales, L.
    Apablaza, C.
    Goity, L.
    Erazo, S.
    Negrete, R.
    Theodoluz, C.
    Rodriguez, J.
    Delporte, C.
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2008, 116 (02) : 263 - 269
  • [8] Badet C, 2008, ORAL HLTH PREV DENT, V6, P337
  • [9] Influence of Excipients on the Antimicrobial Activity of Tobramycin Against Pseudomonas aeruginosa Biofilms
    Bahamondez-Canas, Tania
    Smyth, Hugh D. C.
    [J]. PHARMACEUTICAL RESEARCH, 2018, 35 (01)
  • [10] Development, Characterization, and In Vitro Testing of Co-Delivered Antimicrobial Dry Powder Formulation for the Treatment of Pseudomonas aeruginosa Biofilms
    Bahamondez-Canas, Tania F.
    Ferrati, Silvia
    Moraga-Espinoza, Daniel F.
    Smyth, Hugh D. C.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (08) : 2172 - 2178